Impaired Membrane Transport in Methotrexate-resistant CCRF-CEM Cells Involves Early Translation Termination and Increased Turnover of a Mutant Reduced Folate Carrier

This publication has 25 references indexed in Scilit:

• A Mutated Murine Reduced Folate Carrier (RFC1) with Increased Affinity for Folic Acid, Decreased Affinity for Methotrexate, and an Obligatory Anion Requirement for Transport Function
  Published by Elsevier ,1998
• A Reduced Folate Carrier Mutation Produces Substrate-dependent Alterations in Carrier Mobility in Murine Leukemia Cells and Methotrexate Resistance with Conservation of Growth in 5-Formyltetrahydrofolate
  Journal of Biological Chemistry, 1998
• A Single Amino Acid Difference within the Folate Transporter Encoded by the Murine RFC-1 Gene Selectively Alters its Interaction with Folate Analogues
  Published by Elsevier ,1998
• pH Dependence of methotrexate transport by the reduced folate carrier and the folate receptor in L1210 leukemia cells: Further evidence for a third route mediated at low pH
  Biochemical Pharmacology, 1997
• Human k562 transfectants expressing high levels of reduced folate carrier but exhibiting low transport activity
  Biochemical Pharmacology, 1997
• Characterization of a Mutation in the Reduced Folate Carrier in a Transport Defective L1210 Murine Leukemia Cell Line
  Published by Elsevier ,1995
• Determinants of the disparate antitumor activities of (6R)-5,10-dideaza-5,6,7,8-tetrahydrofolate and methotrexate toward human lymphoblastic leukemia cells, characterized by severely impaired antifolate membrane transport
  Biochemical Pharmacology, 1993
• Carrier-mediated transport of folate compounds in L1210 cells
  Biochemical Pharmacology, 1987
• The cellular pharmacology of methotrexate
  Pharmacology & Therapeutics, 1985
• Effects of methotrexate esters and other lipophilic antifolates on methotrexate-resistant human leukemic lymphoblasts
  Biochemical Pharmacology, 1980